Neurocrine Biosciences (NBIX) Misses Q4 EPS by 11c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $174.26 +3.87%
EPS Growth %: -4.2%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
More
EPS Growth %: -4.2%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $0.07, $0.11 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $94.52 million versus the consensus estimate of $87.77 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Lucid reports Q2 output, names new CFO and five other leaders
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
